Cargando…

Targeted therapy for head and neck cancer: signaling pathways and clinical studies

Head and neck cancer (HNC) is malignant, genetically complex and difficult to treat and is the sixth most frequent cancer, with tobacco, alcohol and human papillomavirus being major risk factors. Based on epigenetic data, HNC is remarkably heterogeneous, and treatment remains challenging. There is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qingfang, Tie, Yan, Alu, Aqu, Ma, Xuelei, Shi, Huashan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842704/ https://www.ncbi.nlm.nih.gov/pubmed/36646686 http://dx.doi.org/10.1038/s41392-022-01297-0

Ejemplares similares

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
por: Li, Qingfang, et al.
Publicado: (2022)

The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020)

cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020)

Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods
por: Han, Xuejiao, et al.
Publicado: (2021)

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
por: Han, Xuejiao, et al.
Publicado: (2022)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022)

TGF-beta signal transduction: biology, function and therapy for diseases
por: Tie, Yan, et al.
Publicado: (2022)

Targeted therapy in head/neck and gastric cancers
por: Hsueh, Chung-Tsen
Publicado: (2012)

Progress of molecular targeted therapy for head and neck cancer in clinical aspects
por: Nakano, Kenji
Publicado: (2021)

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
por: Yang, Jingyun, et al.
Publicado: (2023)

Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers
por: Glorieux, Mary, et al.
Publicado: (2017)

The modulatory effect of high salt on immune cells and related diseases
por: Li, Xian, et al.
Publicado: (2022)

Safety and efficacy profile of cyclin‐dependent kinases 4/6 inhibitor palbociclib in cancer therapy: A meta‐analysis of clinical trials
por: Guo, Linghong, et al.
Publicado: (2019)

Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer
por: Li, Zhipeng, et al.
Publicado: (2018)

Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer
por: Elferink, Lisa A., et al.
Publicado: (2011)

Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
por: Espinosa, Maria L., et al.
Publicado: (2021)

Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
por: Santos-de-Frutos, Karla, et al.
Publicado: (2019)

The value of narrow band imaging in diagnosis of head and neck cancer: a meta-analysis
por: Zhou, Hui, et al.
Publicado: (2018)

The Value of CEUS in Distinguishing Cancerous Lymph Nodes From the Primary Lymphoma of the Head and Neck
por: Nie, Ji, et al.
Publicado: (2020)

Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit
por: Johnson, Daniel E.
Publicado: (2012)

Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer
por: Bos, Tasia, et al.
Publicado: (2021)

Precision drugging of the MAPK pathway in head and neck cancer
por: Ngan, Hoi-Lam, et al.
Publicado: (2022)

Targeting Head and Neck Cancer by Vaccination
por: Wang, Chuan, et al.
Publicado: (2018)

Molecular targeted therapies in head and neck cancer - An update of recent developements -
por: Goerner, Martin, et al.
Publicado: (2010)

Nucleic Acid Targeting: Towards Personalized Therapy for Head and Neck Cancer
por: Parsel, Sean M, et al.
Publicado: (2015)

mTOR co-targeting strategies for head and neck cancer therapy
por: Wang, Zhiyong, et al.
Publicado: (2017)

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

IL-10 and integrin signaling pathways are associated with head and neck cancer progression
por: Bornstein, Sophia, et al.
Publicado: (2016)

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
por: Ni, Yanghong, et al.
Publicado: (2021)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

Photodynamic Therapy for Head and Neck Cancer
por: Yoshida, Tomoyuki, et al.
Publicado: (1996)

Radiation therapy in head and neck cancer
por: Alfouzan, Afnan F.
Publicado: (2021)

Speech therapy in head and neck cancer
por: Rossi, Vaneli Colombo, et al.
Publicado: (2021)

Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
por: Gougis, Paul, et al.
Publicado: (2019)

mTOR Signalling in Head and Neck Cancer: Heads Up
por: Tan, Fiona H., et al.
Publicado: (2019)

Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers
por: Ettl, Tobias, et al.
Publicado: (2022)

Genome Stability Pathways in Head and Neck Cancers
por: Jenkins, Glenn, et al.
Publicado: (2013)

Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma
por: Cai, Yi, et al.
Publicado: (2017)

Defining the target for radiotherapy of head and neck cancer
por: Nuyts, S.
Publicado: (2007)

Kaempferol and Fisetin-Related Signaling Pathways Induce Apoptosis in Head and Neck Cancer Cells
por: Kubina, Robert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_thqd6057tmc7pv1v1nb39q4td8